Pharma & Healthcare
Global mRNA Vaccines & Therapeutics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Aug 11, 25
- ID: 436592
- Pages: 76
- Figures: 78
- Views: 3
The global mRNA Vaccines & Therapeutics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
By Type: (Dominant Segment vs High-Margin Innovation)
Infectious Disease Vaccines
Cancer Vaccines
By Application: (Core Demand Driver vs Emerging Opportunity)
Infectious Disease
Cancer
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Moderna Therapeutics in Europe)
- Emerging Product Trends: Infectious Disease Vaccines adoption vs. Cancer Vaccines premiumization
- Demand-Side Dynamics: Infectious Disease growth in China vs. Cancer potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of mRNA Vaccines & Therapeutics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Cancer Vaccines in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cancer in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Infectious Disease Vaccines dominance in Europe vs. Cancer Vaccines demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Market Segmentation
By Company:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
By Type: (Dominant Segment vs High-Margin Innovation)
Infectious Disease Vaccines
Cancer Vaccines
By Application: (Core Demand Driver vs Emerging Opportunity)
Infectious Disease
Cancer
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Moderna Therapeutics in Europe)
- Emerging Product Trends: Infectious Disease Vaccines adoption vs. Cancer Vaccines premiumization
- Demand-Side Dynamics: Infectious Disease growth in China vs. Cancer potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of mRNA Vaccines & Therapeutics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Cancer Vaccines in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cancer in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Infectious Disease Vaccines dominance in Europe vs. Cancer Vaccines demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 mRNA Vaccines & Therapeutics Product Scope
1.2 mRNA Vaccines & Therapeutics by Type
1.2.1 Global mRNA Vaccines & Therapeutics Sales by Type (2020 & 2024 & 2031)
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 mRNA Vaccines & Therapeutics by Application
1.3.1 Global mRNA Vaccines & Therapeutics Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts (2020-2031)
1.4.1 Global mRNA Vaccines & Therapeutics Market Size in Value Growth Rate (2020-2031)
1.4.2 Global mRNA Vaccines & Therapeutics Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global mRNA Vaccines & Therapeutics Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global mRNA Vaccines & Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global mRNA Vaccines & Therapeutics Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2020-2025)
2.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2020-2025)
2.3 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global mRNA Vaccines & Therapeutics Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America mRNA Vaccines & Therapeutics Market Size and Prospective (2020-2031)
2.4.2 Europe mRNA Vaccines & Therapeutics Market Size and Prospective (2020-2031)
2.4.3 China mRNA Vaccines & Therapeutics Market Size and Prospective (2020-2031)
2.4.4 Japan mRNA Vaccines & Therapeutics Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global mRNA Vaccines & Therapeutics Historic Market Review by Type (2020-2025)
3.1.1 Global mRNA Vaccines & Therapeutics Sales by Type (2020-2025)
3.1.2 Global mRNA Vaccines & Therapeutics Revenue by Type (2020-2025)
3.1.3 Global mRNA Vaccines & Therapeutics Price by Type (2020-2025)
3.2 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2026-2031)
3.2.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2026-2031)
3.2.3 Global mRNA Vaccines & Therapeutics Price Forecast by Type (2026-2031)
3.3 Different Types mRNA Vaccines & Therapeutics Representative Players
4 Global Market Size by Application
4.1 Global mRNA Vaccines & Therapeutics Historic Market Review by Application (2020-2025)
4.1.1 Global mRNA Vaccines & Therapeutics Sales by Application (2020-2025)
4.1.2 Global mRNA Vaccines & Therapeutics Revenue by Application (2020-2025)
4.1.3 Global mRNA Vaccines & Therapeutics Price by Application (2020-2025)
4.2 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2026-2031)
4.2.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Application (2026-2031)
4.2.3 Global mRNA Vaccines & Therapeutics Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in mRNA Vaccines & Therapeutics Application
5 Competition Landscape by Players
5.1 Global mRNA Vaccines & Therapeutics Sales by Players (2020-2025)
5.2 Global Top mRNA Vaccines & Therapeutics Players by Revenue (2020-2025)
5.3 Global mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines & Therapeutics as of 2024)
5.4 Global mRNA Vaccines & Therapeutics Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of mRNA Vaccines & Therapeutics, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of mRNA Vaccines & Therapeutics, Product Type & Application
5.7 Global Key Manufacturers of mRNA Vaccines & Therapeutics, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America mRNA Vaccines & Therapeutics Sales by Company
6.1.1.1 North America mRNA Vaccines & Therapeutics Sales by Company (2020-2025)
6.1.1.2 North America mRNA Vaccines & Therapeutics Revenue by Company (2020-2025)
6.1.2 North America mRNA Vaccines & Therapeutics Sales Breakdown by Type (2020-2025)
6.1.3 North America mRNA Vaccines & Therapeutics Sales Breakdown by Application (2020-2025)
6.1.4 North America mRNA Vaccines & Therapeutics Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe mRNA Vaccines & Therapeutics Sales by Company
6.2.1.1 Europe mRNA Vaccines & Therapeutics Sales by Company (2020-2025)
6.2.1.2 Europe mRNA Vaccines & Therapeutics Revenue by Company (2020-2025)
6.2.2 Europe mRNA Vaccines & Therapeutics Sales Breakdown by Type (2020-2025)
6.2.3 Europe mRNA Vaccines & Therapeutics Sales Breakdown by Application (2020-2025)
6.2.4 Europe mRNA Vaccines & Therapeutics Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China mRNA Vaccines & Therapeutics Sales by Company
6.3.1.1 China mRNA Vaccines & Therapeutics Sales by Company (2020-2025)
6.3.1.2 China mRNA Vaccines & Therapeutics Revenue by Company (2020-2025)
6.3.2 China mRNA Vaccines & Therapeutics Sales Breakdown by Type (2020-2025)
6.3.3 China mRNA Vaccines & Therapeutics Sales Breakdown by Application (2020-2025)
6.3.4 China mRNA Vaccines & Therapeutics Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan mRNA Vaccines & Therapeutics Sales by Company
6.4.1.1 Japan mRNA Vaccines & Therapeutics Sales by Company (2020-2025)
6.4.1.2 Japan mRNA Vaccines & Therapeutics Revenue by Company (2020-2025)
6.4.2 Japan mRNA Vaccines & Therapeutics Sales Breakdown by Type (2020-2025)
6.4.3 Japan mRNA Vaccines & Therapeutics Sales Breakdown by Application (2020-2025)
6.4.4 Japan mRNA Vaccines & Therapeutics Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Moderna Therapeutics
7.1.1 Moderna Therapeutics Company Information
7.1.2 Moderna Therapeutics Business Overview
7.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Products Offered
7.1.5 Moderna Therapeutics Recent Development
7.2 CureVac
7.2.1 CureVac Company Information
7.2.2 CureVac Business Overview
7.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.2.4 CureVac mRNA Vaccines & Therapeutics Products Offered
7.2.5 CureVac Recent Development
7.3 Translate Bio
7.3.1 Translate Bio Company Information
7.3.2 Translate Bio Business Overview
7.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Translate Bio mRNA Vaccines & Therapeutics Products Offered
7.3.5 Translate Bio Recent Development
7.4 BioNTech
7.4.1 BioNTech Company Information
7.4.2 BioNTech Business Overview
7.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.4.4 BioNTech mRNA Vaccines & Therapeutics Products Offered
7.4.5 BioNTech Recent Development
7.5 Sangamo Therapeutics
7.5.1 Sangamo Therapeutics Company Information
7.5.2 Sangamo Therapeutics Business Overview
7.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Products Offered
7.5.5 Sangamo Therapeutics Recent Development
7.6 Argos Therapeutics
7.6.1 Argos Therapeutics Company Information
7.6.2 Argos Therapeutics Business Overview
7.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Products Offered
7.6.5 Argos Therapeutics Recent Development
7.7 In-Cell-Art
7.7.1 In-Cell-Art Company Information
7.7.2 In-Cell-Art Business Overview
7.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Products Offered
7.7.5 In-Cell-Art Recent Development
7.8 eTheRNA
7.8.1 eTheRNA Company Information
7.8.2 eTheRNA Business Overview
7.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.8.4 eTheRNA mRNA Vaccines & Therapeutics Products Offered
7.8.5 eTheRNA Recent Development
7.9 Ethris
7.9.1 Ethris Company Information
7.9.2 Ethris Business Overview
7.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Ethris mRNA Vaccines & Therapeutics Products Offered
7.9.5 Ethris Recent Development
7.10 Tiba Biotechnology
7.10.1 Tiba Biotechnology Company Information
7.10.2 Tiba Biotechnology Business Overview
7.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Products Offered
7.10.5 Tiba Biotechnology Recent Development
8 mRNA Vaccines & Therapeutics Manufacturing Cost Analysis
8.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
8.4 mRNA Vaccines & Therapeutics Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 mRNA Vaccines & Therapeutics Distributors List
9.3 mRNA Vaccines & Therapeutics Customers
10 mRNA Vaccines & Therapeutics Market Dynamics
10.1 mRNA Vaccines & Therapeutics Industry Trends
10.2 mRNA Vaccines & Therapeutics Market Drivers
10.3 mRNA Vaccines & Therapeutics Market Challenges
10.4 mRNA Vaccines & Therapeutics Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 mRNA Vaccines & Therapeutics Product Scope
1.2 mRNA Vaccines & Therapeutics by Type
1.2.1 Global mRNA Vaccines & Therapeutics Sales by Type (2020 & 2024 & 2031)
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 mRNA Vaccines & Therapeutics by Application
1.3.1 Global mRNA Vaccines & Therapeutics Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts (2020-2031)
1.4.1 Global mRNA Vaccines & Therapeutics Market Size in Value Growth Rate (2020-2031)
1.4.2 Global mRNA Vaccines & Therapeutics Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global mRNA Vaccines & Therapeutics Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global mRNA Vaccines & Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global mRNA Vaccines & Therapeutics Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2020-2025)
2.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2020-2025)
2.3 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global mRNA Vaccines & Therapeutics Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America mRNA Vaccines & Therapeutics Market Size and Prospective (2020-2031)
2.4.2 Europe mRNA Vaccines & Therapeutics Market Size and Prospective (2020-2031)
2.4.3 China mRNA Vaccines & Therapeutics Market Size and Prospective (2020-2031)
2.4.4 Japan mRNA Vaccines & Therapeutics Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global mRNA Vaccines & Therapeutics Historic Market Review by Type (2020-2025)
3.1.1 Global mRNA Vaccines & Therapeutics Sales by Type (2020-2025)
3.1.2 Global mRNA Vaccines & Therapeutics Revenue by Type (2020-2025)
3.1.3 Global mRNA Vaccines & Therapeutics Price by Type (2020-2025)
3.2 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2026-2031)
3.2.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2026-2031)
3.2.3 Global mRNA Vaccines & Therapeutics Price Forecast by Type (2026-2031)
3.3 Different Types mRNA Vaccines & Therapeutics Representative Players
4 Global Market Size by Application
4.1 Global mRNA Vaccines & Therapeutics Historic Market Review by Application (2020-2025)
4.1.1 Global mRNA Vaccines & Therapeutics Sales by Application (2020-2025)
4.1.2 Global mRNA Vaccines & Therapeutics Revenue by Application (2020-2025)
4.1.3 Global mRNA Vaccines & Therapeutics Price by Application (2020-2025)
4.2 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2026-2031)
4.2.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Application (2026-2031)
4.2.3 Global mRNA Vaccines & Therapeutics Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in mRNA Vaccines & Therapeutics Application
5 Competition Landscape by Players
5.1 Global mRNA Vaccines & Therapeutics Sales by Players (2020-2025)
5.2 Global Top mRNA Vaccines & Therapeutics Players by Revenue (2020-2025)
5.3 Global mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines & Therapeutics as of 2024)
5.4 Global mRNA Vaccines & Therapeutics Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of mRNA Vaccines & Therapeutics, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of mRNA Vaccines & Therapeutics, Product Type & Application
5.7 Global Key Manufacturers of mRNA Vaccines & Therapeutics, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America mRNA Vaccines & Therapeutics Sales by Company
6.1.1.1 North America mRNA Vaccines & Therapeutics Sales by Company (2020-2025)
6.1.1.2 North America mRNA Vaccines & Therapeutics Revenue by Company (2020-2025)
6.1.2 North America mRNA Vaccines & Therapeutics Sales Breakdown by Type (2020-2025)
6.1.3 North America mRNA Vaccines & Therapeutics Sales Breakdown by Application (2020-2025)
6.1.4 North America mRNA Vaccines & Therapeutics Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe mRNA Vaccines & Therapeutics Sales by Company
6.2.1.1 Europe mRNA Vaccines & Therapeutics Sales by Company (2020-2025)
6.2.1.2 Europe mRNA Vaccines & Therapeutics Revenue by Company (2020-2025)
6.2.2 Europe mRNA Vaccines & Therapeutics Sales Breakdown by Type (2020-2025)
6.2.3 Europe mRNA Vaccines & Therapeutics Sales Breakdown by Application (2020-2025)
6.2.4 Europe mRNA Vaccines & Therapeutics Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China mRNA Vaccines & Therapeutics Sales by Company
6.3.1.1 China mRNA Vaccines & Therapeutics Sales by Company (2020-2025)
6.3.1.2 China mRNA Vaccines & Therapeutics Revenue by Company (2020-2025)
6.3.2 China mRNA Vaccines & Therapeutics Sales Breakdown by Type (2020-2025)
6.3.3 China mRNA Vaccines & Therapeutics Sales Breakdown by Application (2020-2025)
6.3.4 China mRNA Vaccines & Therapeutics Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan mRNA Vaccines & Therapeutics Sales by Company
6.4.1.1 Japan mRNA Vaccines & Therapeutics Sales by Company (2020-2025)
6.4.1.2 Japan mRNA Vaccines & Therapeutics Revenue by Company (2020-2025)
6.4.2 Japan mRNA Vaccines & Therapeutics Sales Breakdown by Type (2020-2025)
6.4.3 Japan mRNA Vaccines & Therapeutics Sales Breakdown by Application (2020-2025)
6.4.4 Japan mRNA Vaccines & Therapeutics Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Moderna Therapeutics
7.1.1 Moderna Therapeutics Company Information
7.1.2 Moderna Therapeutics Business Overview
7.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Products Offered
7.1.5 Moderna Therapeutics Recent Development
7.2 CureVac
7.2.1 CureVac Company Information
7.2.2 CureVac Business Overview
7.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.2.4 CureVac mRNA Vaccines & Therapeutics Products Offered
7.2.5 CureVac Recent Development
7.3 Translate Bio
7.3.1 Translate Bio Company Information
7.3.2 Translate Bio Business Overview
7.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Translate Bio mRNA Vaccines & Therapeutics Products Offered
7.3.5 Translate Bio Recent Development
7.4 BioNTech
7.4.1 BioNTech Company Information
7.4.2 BioNTech Business Overview
7.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.4.4 BioNTech mRNA Vaccines & Therapeutics Products Offered
7.4.5 BioNTech Recent Development
7.5 Sangamo Therapeutics
7.5.1 Sangamo Therapeutics Company Information
7.5.2 Sangamo Therapeutics Business Overview
7.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Products Offered
7.5.5 Sangamo Therapeutics Recent Development
7.6 Argos Therapeutics
7.6.1 Argos Therapeutics Company Information
7.6.2 Argos Therapeutics Business Overview
7.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Products Offered
7.6.5 Argos Therapeutics Recent Development
7.7 In-Cell-Art
7.7.1 In-Cell-Art Company Information
7.7.2 In-Cell-Art Business Overview
7.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Products Offered
7.7.5 In-Cell-Art Recent Development
7.8 eTheRNA
7.8.1 eTheRNA Company Information
7.8.2 eTheRNA Business Overview
7.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.8.4 eTheRNA mRNA Vaccines & Therapeutics Products Offered
7.8.5 eTheRNA Recent Development
7.9 Ethris
7.9.1 Ethris Company Information
7.9.2 Ethris Business Overview
7.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Ethris mRNA Vaccines & Therapeutics Products Offered
7.9.5 Ethris Recent Development
7.10 Tiba Biotechnology
7.10.1 Tiba Biotechnology Company Information
7.10.2 Tiba Biotechnology Business Overview
7.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Products Offered
7.10.5 Tiba Biotechnology Recent Development
8 mRNA Vaccines & Therapeutics Manufacturing Cost Analysis
8.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
8.4 mRNA Vaccines & Therapeutics Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 mRNA Vaccines & Therapeutics Distributors List
9.3 mRNA Vaccines & Therapeutics Customers
10 mRNA Vaccines & Therapeutics Market Dynamics
10.1 mRNA Vaccines & Therapeutics Industry Trends
10.2 mRNA Vaccines & Therapeutics Market Drivers
10.3 mRNA Vaccines & Therapeutics Market Challenges
10.4 mRNA Vaccines & Therapeutics Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global mRNA Vaccines & Therapeutics Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global mRNA Vaccines & Therapeutics Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market mRNA Vaccines & Therapeutics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Region (2020-2025)
Table 5. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2020-2025)
Table 6. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global mRNA Vaccines & Therapeutics Revenue Share by Region (2020-2025)
Table 8. Global mRNA Vaccines & Therapeutics Sales (M Doses) Forecast by Region (2026-2031)
Table 9. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Region (2026-2031)
Table 10. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global mRNA Vaccines & Therapeutics Revenue Share Forecast by Region (2026-2031)
Table 12. Global mRNA Vaccines & Therapeutics Sales by Type (M Doses) & (2020-2025)
Table 13. Global mRNA Vaccines & Therapeutics Sales Share by Type (2020-2025)
Table 14. Global mRNA Vaccines & Therapeutics Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global mRNA Vaccines & Therapeutics Price by Type (USD/Doses) & (2020-2025)
Table 16. Global mRNA Vaccines & Therapeutics Sales by Type (M Doses) & (2026-2031)
Table 17. Global mRNA Vaccines & Therapeutics Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global mRNA Vaccines & Therapeutics Price by Type (USD/Doses) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global mRNA Vaccines & Therapeutics Sales by Application (M Doses) & (2020-2025)
Table 21. Global mRNA Vaccines & Therapeutics Sales Share by Application (2020-2025)
Table 22. Global mRNA Vaccines & Therapeutics Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global mRNA Vaccines & Therapeutics Price by Application (USD/Doses) & (2020-2025)
Table 24. Global mRNA Vaccines & Therapeutics Sales by Application (M Doses) & (2026-2031)
Table 25. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global mRNA Vaccines & Therapeutics Price by Application (USD/Doses) & (2026-2031)
Table 27. New Sources of Growth in mRNA Vaccines & Therapeutics Application
Table 28. Global mRNA Vaccines & Therapeutics Sales by Company (M Doses) & (2020-2025)
Table 29. Global mRNA Vaccines & Therapeutics Sales Share by Company (2020-2025)
Table 30. Global mRNA Vaccines & Therapeutics Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global mRNA Vaccines & Therapeutics Revenue Share by Company (2020-2025)
Table 32. Global mRNA Vaccines & Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines & Therapeutics as of 2024)
Table 33. Global Market mRNA Vaccines & Therapeutics Average Price by Company (USD/Doses) & (2020-2025)
Table 34. Global Key Manufacturers of mRNA Vaccines & Therapeutics, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of mRNA Vaccines & Therapeutics, Product Type & Application
Table 36. Global Key Manufacturers of mRNA Vaccines & Therapeutics, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America mRNA Vaccines & Therapeutics Sales by Company (2020-2025) & (M Doses)
Table 39. North America mRNA Vaccines & Therapeutics Sales Market Share by Company (2020-2025)
Table 40. North America mRNA Vaccines & Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America mRNA Vaccines & Therapeutics Revenue Market Share by Company (2020-2025)
Table 42. North America mRNA Vaccines & Therapeutics Sales by Type (2020-2025) & (M Doses)
Table 43. North America mRNA Vaccines & Therapeutics Sales Market Share by Type (2020-2025)
Table 44. North America mRNA Vaccines & Therapeutics Sales by Application (2020-2025) & (M Doses)
Table 45. North America mRNA Vaccines & Therapeutics Sales Market Share by Application (2020-2025)
Table 46. Europe mRNA Vaccines & Therapeutics Sales by Company (2020-2025) & (M Doses)
Table 47. Europe mRNA Vaccines & Therapeutics Sales Market Share by Company (2020-2025)
Table 48. Europe mRNA Vaccines & Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Company (2020-2025)
Table 50. Europe mRNA Vaccines & Therapeutics Sales by Type (2020-2025) & (M Doses)
Table 51. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2020-2025)
Table 52. Europe mRNA Vaccines & Therapeutics Sales by Application (2020-2025) & (M Doses)
Table 53. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2020-2025)
Table 54. China mRNA Vaccines & Therapeutics Sales by Company (2020-2025) & (M Doses)
Table 55. China mRNA Vaccines & Therapeutics Sales Market Share by Company (2020-2025)
Table 56. China mRNA Vaccines & Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 57. China mRNA Vaccines & Therapeutics Revenue Market Share by Company (2020-2025)
Table 58. China mRNA Vaccines & Therapeutics Sales by Type (2020-2025) & (M Doses)
Table 59. China mRNA Vaccines & Therapeutics Sales Market Share by Type (2020-2025)
Table 60. China mRNA Vaccines & Therapeutics Sales by Application (2020-2025) & (M Doses)
Table 61. China mRNA Vaccines & Therapeutics Sales Market Share by Application (2020-2025)
Table 62. Japan mRNA Vaccines & Therapeutics Sales by Company (2020-2025) & (M Doses)
Table 63. Japan mRNA Vaccines & Therapeutics Sales Market Share by Company (2020-2025)
Table 64. Japan mRNA Vaccines & Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan mRNA Vaccines & Therapeutics Revenue Market Share by Company (2020-2025)
Table 66. Japan mRNA Vaccines & Therapeutics Sales by Type (2020-2025) & (M Doses)
Table 67. Japan mRNA Vaccines & Therapeutics Sales Market Share by Type (2020-2025)
Table 68. Japan mRNA Vaccines & Therapeutics Sales by Application (2020-2025) & (M Doses)
Table 69. Japan mRNA Vaccines & Therapeutics Sales Market Share by Application (2020-2025)
Table 70. Moderna Therapeutics Company Information
Table 71. Moderna Therapeutics Description and Business Overview
Table 72. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 73. Moderna Therapeutics mRNA Vaccines & Therapeutics Product
Table 74. Moderna Therapeutics Recent Development
Table 75. CureVac Company Information
Table 76. CureVac Description and Business Overview
Table 77. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 78. CureVac mRNA Vaccines & Therapeutics Product
Table 79. CureVac Recent Development
Table 80. Translate Bio Company Information
Table 81. Translate Bio Description and Business Overview
Table 82. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 83. Translate Bio mRNA Vaccines & Therapeutics Product
Table 84. Translate Bio Recent Development
Table 85. BioNTech Company Information
Table 86. BioNTech Description and Business Overview
Table 87. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 88. BioNTech mRNA Vaccines & Therapeutics Product
Table 89. BioNTech Recent Development
Table 90. Sangamo Therapeutics Company Information
Table 91. Sangamo Therapeutics Description and Business Overview
Table 92. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 93. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product
Table 94. Sangamo Therapeutics Recent Development
Table 95. Argos Therapeutics Company Information
Table 96. Argos Therapeutics Description and Business Overview
Table 97. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 98. Argos Therapeutics mRNA Vaccines & Therapeutics Product
Table 99. Argos Therapeutics Recent Development
Table 100. In-Cell-Art Company Information
Table 101. In-Cell-Art Description and Business Overview
Table 102. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 103. In-Cell-Art mRNA Vaccines & Therapeutics Product
Table 104. In-Cell-Art Recent Development
Table 105. eTheRNA Company Information
Table 106. eTheRNA Description and Business Overview
Table 107. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 108. eTheRNA mRNA Vaccines & Therapeutics Product
Table 109. eTheRNA Recent Development
Table 110. Ethris Company Information
Table 111. Ethris Description and Business Overview
Table 112. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 113. Ethris mRNA Vaccines & Therapeutics Product
Table 114. Ethris Recent Development
Table 115. Tiba Biotechnology Company Information
Table 116. Tiba Biotechnology Description and Business Overview
Table 117. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 118. Tiba Biotechnology mRNA Vaccines & Therapeutics Product
Table 119. Tiba Biotechnology Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. mRNA Vaccines & Therapeutics Distributors List
Table 123. mRNA Vaccines & Therapeutics Customers List
Table 124. mRNA Vaccines & Therapeutics Market Trends
Table 125. mRNA Vaccines & Therapeutics Market Drivers
Table 126. mRNA Vaccines & Therapeutics Market Challenges
Table 127. mRNA Vaccines & Therapeutics Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. mRNA Vaccines & Therapeutics Product Picture
Figure 2. Global mRNA Vaccines & Therapeutics Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global mRNA Vaccines & Therapeutics Sales Market Share by Type in 2024 & 2031
Figure 4. Infectious Disease Vaccines Product Picture
Figure 5. Cancer Vaccines Product Picture
Figure 6. Global mRNA Vaccines & Therapeutics Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global mRNA Vaccines & Therapeutics Sales Market Share by Application in 2024 & 2031
Figure 8. Infectious Disease Examples
Figure 9. Cancer Examples
Figure 10. Global mRNA Vaccines & Therapeutics Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global mRNA Vaccines & Therapeutics Sales Growth Rate (2020-2031) & (US$ Million)
Figure 12. Global mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2020-2031)
Figure 13. Global mRNA Vaccines & Therapeutics Price Trends Growth Rate (2020-2031) & (USD/Doses)
Figure 14. mRNA Vaccines & Therapeutics Report Years Considered
Figure 15. Global Market mRNA Vaccines & Therapeutics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 16. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region: 2020 VS 2024
Figure 17. North America mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. North America mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2020-2031)
Figure 19. Europe mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2020-2031)
Figure 21. China mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. China mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2020-2031)
Figure 23. Japan mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Japan mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2020-2031)
Figure 25. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2020-2025)
Figure 26. Global mRNA Vaccines & Therapeutics Sales Share by Type (2026-2031)
Figure 27. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2026-2031)
Figure 28. Global mRNA Vaccines & Therapeutics Revenue Share by Application (2020-2025)
Figure 29. Global mRNA Vaccines & Therapeutics Revenue Growth Rate by Application in 2020 & 2024
Figure 30. Global mRNA Vaccines & Therapeutics Sales Share by Application (2026-2031)
Figure 31. Global mRNA Vaccines & Therapeutics Revenue Share by Application (2026-2031)
Figure 32. Global mRNA Vaccines & Therapeutics Sales Share by Company (2024)
Figure 33. Global mRNA Vaccines & Therapeutics Revenue Share by Company (2024)
Figure 34. Global 5 Largest mRNA Vaccines & Therapeutics Players Market Share by Revenue in mRNA Vaccines & Therapeutics: 2020 & 2024
Figure 35. mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 36. Manufacturing Cost Structure of mRNA Vaccines & Therapeutics
Figure 37. Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
Figure 38. mRNA Vaccines & Therapeutics Industrial Chain
Figure 39. Channels of Distribution (Direct Vs Distribution)
Figure 40. Distributors Profiles
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
Table 1. Global mRNA Vaccines & Therapeutics Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global mRNA Vaccines & Therapeutics Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market mRNA Vaccines & Therapeutics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Region (2020-2025)
Table 5. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2020-2025)
Table 6. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global mRNA Vaccines & Therapeutics Revenue Share by Region (2020-2025)
Table 8. Global mRNA Vaccines & Therapeutics Sales (M Doses) Forecast by Region (2026-2031)
Table 9. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Region (2026-2031)
Table 10. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global mRNA Vaccines & Therapeutics Revenue Share Forecast by Region (2026-2031)
Table 12. Global mRNA Vaccines & Therapeutics Sales by Type (M Doses) & (2020-2025)
Table 13. Global mRNA Vaccines & Therapeutics Sales Share by Type (2020-2025)
Table 14. Global mRNA Vaccines & Therapeutics Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global mRNA Vaccines & Therapeutics Price by Type (USD/Doses) & (2020-2025)
Table 16. Global mRNA Vaccines & Therapeutics Sales by Type (M Doses) & (2026-2031)
Table 17. Global mRNA Vaccines & Therapeutics Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global mRNA Vaccines & Therapeutics Price by Type (USD/Doses) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global mRNA Vaccines & Therapeutics Sales by Application (M Doses) & (2020-2025)
Table 21. Global mRNA Vaccines & Therapeutics Sales Share by Application (2020-2025)
Table 22. Global mRNA Vaccines & Therapeutics Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global mRNA Vaccines & Therapeutics Price by Application (USD/Doses) & (2020-2025)
Table 24. Global mRNA Vaccines & Therapeutics Sales by Application (M Doses) & (2026-2031)
Table 25. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global mRNA Vaccines & Therapeutics Price by Application (USD/Doses) & (2026-2031)
Table 27. New Sources of Growth in mRNA Vaccines & Therapeutics Application
Table 28. Global mRNA Vaccines & Therapeutics Sales by Company (M Doses) & (2020-2025)
Table 29. Global mRNA Vaccines & Therapeutics Sales Share by Company (2020-2025)
Table 30. Global mRNA Vaccines & Therapeutics Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global mRNA Vaccines & Therapeutics Revenue Share by Company (2020-2025)
Table 32. Global mRNA Vaccines & Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines & Therapeutics as of 2024)
Table 33. Global Market mRNA Vaccines & Therapeutics Average Price by Company (USD/Doses) & (2020-2025)
Table 34. Global Key Manufacturers of mRNA Vaccines & Therapeutics, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of mRNA Vaccines & Therapeutics, Product Type & Application
Table 36. Global Key Manufacturers of mRNA Vaccines & Therapeutics, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America mRNA Vaccines & Therapeutics Sales by Company (2020-2025) & (M Doses)
Table 39. North America mRNA Vaccines & Therapeutics Sales Market Share by Company (2020-2025)
Table 40. North America mRNA Vaccines & Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America mRNA Vaccines & Therapeutics Revenue Market Share by Company (2020-2025)
Table 42. North America mRNA Vaccines & Therapeutics Sales by Type (2020-2025) & (M Doses)
Table 43. North America mRNA Vaccines & Therapeutics Sales Market Share by Type (2020-2025)
Table 44. North America mRNA Vaccines & Therapeutics Sales by Application (2020-2025) & (M Doses)
Table 45. North America mRNA Vaccines & Therapeutics Sales Market Share by Application (2020-2025)
Table 46. Europe mRNA Vaccines & Therapeutics Sales by Company (2020-2025) & (M Doses)
Table 47. Europe mRNA Vaccines & Therapeutics Sales Market Share by Company (2020-2025)
Table 48. Europe mRNA Vaccines & Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Company (2020-2025)
Table 50. Europe mRNA Vaccines & Therapeutics Sales by Type (2020-2025) & (M Doses)
Table 51. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2020-2025)
Table 52. Europe mRNA Vaccines & Therapeutics Sales by Application (2020-2025) & (M Doses)
Table 53. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2020-2025)
Table 54. China mRNA Vaccines & Therapeutics Sales by Company (2020-2025) & (M Doses)
Table 55. China mRNA Vaccines & Therapeutics Sales Market Share by Company (2020-2025)
Table 56. China mRNA Vaccines & Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 57. China mRNA Vaccines & Therapeutics Revenue Market Share by Company (2020-2025)
Table 58. China mRNA Vaccines & Therapeutics Sales by Type (2020-2025) & (M Doses)
Table 59. China mRNA Vaccines & Therapeutics Sales Market Share by Type (2020-2025)
Table 60. China mRNA Vaccines & Therapeutics Sales by Application (2020-2025) & (M Doses)
Table 61. China mRNA Vaccines & Therapeutics Sales Market Share by Application (2020-2025)
Table 62. Japan mRNA Vaccines & Therapeutics Sales by Company (2020-2025) & (M Doses)
Table 63. Japan mRNA Vaccines & Therapeutics Sales Market Share by Company (2020-2025)
Table 64. Japan mRNA Vaccines & Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan mRNA Vaccines & Therapeutics Revenue Market Share by Company (2020-2025)
Table 66. Japan mRNA Vaccines & Therapeutics Sales by Type (2020-2025) & (M Doses)
Table 67. Japan mRNA Vaccines & Therapeutics Sales Market Share by Type (2020-2025)
Table 68. Japan mRNA Vaccines & Therapeutics Sales by Application (2020-2025) & (M Doses)
Table 69. Japan mRNA Vaccines & Therapeutics Sales Market Share by Application (2020-2025)
Table 70. Moderna Therapeutics Company Information
Table 71. Moderna Therapeutics Description and Business Overview
Table 72. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 73. Moderna Therapeutics mRNA Vaccines & Therapeutics Product
Table 74. Moderna Therapeutics Recent Development
Table 75. CureVac Company Information
Table 76. CureVac Description and Business Overview
Table 77. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 78. CureVac mRNA Vaccines & Therapeutics Product
Table 79. CureVac Recent Development
Table 80. Translate Bio Company Information
Table 81. Translate Bio Description and Business Overview
Table 82. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 83. Translate Bio mRNA Vaccines & Therapeutics Product
Table 84. Translate Bio Recent Development
Table 85. BioNTech Company Information
Table 86. BioNTech Description and Business Overview
Table 87. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 88. BioNTech mRNA Vaccines & Therapeutics Product
Table 89. BioNTech Recent Development
Table 90. Sangamo Therapeutics Company Information
Table 91. Sangamo Therapeutics Description and Business Overview
Table 92. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 93. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product
Table 94. Sangamo Therapeutics Recent Development
Table 95. Argos Therapeutics Company Information
Table 96. Argos Therapeutics Description and Business Overview
Table 97. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 98. Argos Therapeutics mRNA Vaccines & Therapeutics Product
Table 99. Argos Therapeutics Recent Development
Table 100. In-Cell-Art Company Information
Table 101. In-Cell-Art Description and Business Overview
Table 102. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 103. In-Cell-Art mRNA Vaccines & Therapeutics Product
Table 104. In-Cell-Art Recent Development
Table 105. eTheRNA Company Information
Table 106. eTheRNA Description and Business Overview
Table 107. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 108. eTheRNA mRNA Vaccines & Therapeutics Product
Table 109. eTheRNA Recent Development
Table 110. Ethris Company Information
Table 111. Ethris Description and Business Overview
Table 112. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 113. Ethris mRNA Vaccines & Therapeutics Product
Table 114. Ethris Recent Development
Table 115. Tiba Biotechnology Company Information
Table 116. Tiba Biotechnology Description and Business Overview
Table 117. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 118. Tiba Biotechnology mRNA Vaccines & Therapeutics Product
Table 119. Tiba Biotechnology Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. mRNA Vaccines & Therapeutics Distributors List
Table 123. mRNA Vaccines & Therapeutics Customers List
Table 124. mRNA Vaccines & Therapeutics Market Trends
Table 125. mRNA Vaccines & Therapeutics Market Drivers
Table 126. mRNA Vaccines & Therapeutics Market Challenges
Table 127. mRNA Vaccines & Therapeutics Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. mRNA Vaccines & Therapeutics Product Picture
Figure 2. Global mRNA Vaccines & Therapeutics Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global mRNA Vaccines & Therapeutics Sales Market Share by Type in 2024 & 2031
Figure 4. Infectious Disease Vaccines Product Picture
Figure 5. Cancer Vaccines Product Picture
Figure 6. Global mRNA Vaccines & Therapeutics Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global mRNA Vaccines & Therapeutics Sales Market Share by Application in 2024 & 2031
Figure 8. Infectious Disease Examples
Figure 9. Cancer Examples
Figure 10. Global mRNA Vaccines & Therapeutics Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global mRNA Vaccines & Therapeutics Sales Growth Rate (2020-2031) & (US$ Million)
Figure 12. Global mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2020-2031)
Figure 13. Global mRNA Vaccines & Therapeutics Price Trends Growth Rate (2020-2031) & (USD/Doses)
Figure 14. mRNA Vaccines & Therapeutics Report Years Considered
Figure 15. Global Market mRNA Vaccines & Therapeutics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 16. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region: 2020 VS 2024
Figure 17. North America mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. North America mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2020-2031)
Figure 19. Europe mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2020-2031)
Figure 21. China mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. China mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2020-2031)
Figure 23. Japan mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Japan mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2020-2031)
Figure 25. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2020-2025)
Figure 26. Global mRNA Vaccines & Therapeutics Sales Share by Type (2026-2031)
Figure 27. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2026-2031)
Figure 28. Global mRNA Vaccines & Therapeutics Revenue Share by Application (2020-2025)
Figure 29. Global mRNA Vaccines & Therapeutics Revenue Growth Rate by Application in 2020 & 2024
Figure 30. Global mRNA Vaccines & Therapeutics Sales Share by Application (2026-2031)
Figure 31. Global mRNA Vaccines & Therapeutics Revenue Share by Application (2026-2031)
Figure 32. Global mRNA Vaccines & Therapeutics Sales Share by Company (2024)
Figure 33. Global mRNA Vaccines & Therapeutics Revenue Share by Company (2024)
Figure 34. Global 5 Largest mRNA Vaccines & Therapeutics Players Market Share by Revenue in mRNA Vaccines & Therapeutics: 2020 & 2024
Figure 35. mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 36. Manufacturing Cost Structure of mRNA Vaccines & Therapeutics
Figure 37. Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
Figure 38. mRNA Vaccines & Therapeutics Industrial Chain
Figure 39. Channels of Distribution (Direct Vs Distribution)
Figure 40. Distributors Profiles
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232